Ambu buys patents worth USD 45 million
Danish medtech group Ambu has acquired intellectual property rights relating to breathing systems which it says supports revenue of USD 45 million. “We want to be masters of our own home,” says CEO Lars Marcher.
BY ELIZABETH MØNSTED JOHANSEN
Denmark’s Ambu says it has acquired a number of patents for a purchase price of USD 9 million. The intellectual property rights relate to one of Ambu’s most important product lines: Breathing circuits, which in total generates an annual revenue of more than USD 45m, mainly in the US.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Ambu CEO expects sales in China to reach US levels
For abonnenter
Ambu CEO: our formula fits well with the hospital market
For abonnenter
